Stapp Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Stapp Wealth Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$235K	Buy
2023 Q4	$216K	Buy
2022 Q4	–	Sell
2022 Q3	$181K	Buy